Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | FFAR2 | O15552 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GCK | P35557 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2657244 | 0.82 | GCK (0.55) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2658792 | 0.82 | NPC1 (0.52) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2661038 | 0.81 | ADORA2A (0.56) | POLBADORA2A | |
| SCHEMBL2656942 | 0.81 | ALDH1A1 (0.50) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2656485 | 0.81 | GCK (0.47) | ALDH1A1FFAR2POLBGCKADORA2A | |
| SCHEMBL2662251 | 0.81 | POLB (0.42) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2656521 | 0.81 | POLB (0.60) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2657292 | 0.80 | CYP1A2 (0.43) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2655818 | 0.80 | FFAR2 (0.45) | ALDH1A1FFAR2POLBGCKCYP1A2 | |
| SCHEMBL2657121 | 0.79 | CYP1A2 (0.45) | ALDH1A1FFAR2POLBGCKCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125735-B1 | 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION | ADVINUS THERAPEUTICS PRIVATE LTD (IN) | 2012-06-27 | — | — | EP | disclosed |